MedTrace Logo

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

NCT02294487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2024-10-03

No results posted yet for this study

Summary

This study will collect blood samples from healthy volunteers and volunteers with multiple myeloma who are going to get the seasonal flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcus vaccines.

The main goal of the study is to start to identify differences in the immune response between multiple myeloma patients and people who don't have multiple myeloma. We hope this will provide important information about the best way and time to vaccinate multiple myeloma patients to flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcus .

Conditions

Sponsors & Collaborators

  • Vince Lombardi Cancer Clinic

    collaborator OTHER

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Michael Thompson, MD, PhD · Wake Forest University Health Sciences

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-30
Primary Completion
2016-01-28
Completion
2017-08-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02294487 on ClinicalTrials.gov